ChemDiv Inc. announced today that Dr. Michael G. Palfreyman has joined the company as Head of Translational Research and Development, where he will oversee the integration of preclinical development and clinical studies.
Dr. Palfreyman is an internationally recognized leader in drug development with a successful scientific and business career spanning 35 years. He brings to ChemDiv a distinguished track record of successful drug development and considerable expertise in CNS pharmacology, pharmacogenomics, and rational drug design.
Dr. Palfreyman’s broad and diverse perspective on drug development derives from his experiences as founder, President, and CSO of Psychiatric Genomics; Senior Scientific Advisor to EnVivo Pharmaceuticals and Vitruvean; cofounder of NOVACE, Senior VP for Research and Development at Anadys (formerly Scriptgen); as well as senior executive and scientific leadership roles at Marion Merrell Dow (Sanofi-Aventis) and Beecham (GlaxoSmithKline). In these roles he successfully developed and demonstrated clinical efficacy of a large number of candidates across multiple therapeutic areas. Dr. Palfreyman holds Ph.D. and D.Sc. degrees and is a member of the Royal Pharmaceutical Society. He continues to be an active scientific contributor, with more than 150 publications and 35 issued patents.
In announcing this appointment, Nikolay Savchuk, CEO and President said “We are very pleased to have Michael Palfreyman join ChemDiv. Michael will be a tremendous addition to our leadership team. He brings us deep industry knowledge and scientific leadership that perfectly complements ChemDiv’s existing strengths in discovery and development. What’s more, Michael is a terrific collaborator and colleague.”
About ChemDiv
ChemDiv Inc. (Chemical Diversity) is a global contract research organization accelerating external discovery and development of novel therapies through comprehensive Discovery outSourceTM services, including discovery biology, medicinal and synthetic chemistry, and pre-clinical and clinical development.
Contact:
Ronald Demuth,
SVP & General Manager, ChemDiv, Inc.
6605 Nancy Ridge Drive, San Diego, CA 92121
Phone: (858) 794-4860; Fax: (858)794-4931,
rdemuth@chemdiv.com
